On the public citation graph

COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics

0 signed · 258 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archinte.160.20.3082openalex-snapshot
A Prospective Study of Age and Lifestyle Factors in Relation to Community-Acquired Pneumonia in US Men and Women
inferredcites →https://doi.org/10.1001/jama.2015.5370openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1001/jama.2020.1585openalex-snapshot
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
inferredcites →https://doi.org/10.1001/jamacardio.2020.1017openalex-snapshot
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
inferredcites →https://doi.org/10.1001/jamacardio.2020.1286openalex-snapshot
Potential Effects of Coronaviruses on the Cardiovascular System
inferredcites →https://doi.org/10.1002/dmrr.3319openalex-snapshot
Diabetes is a risk factor for the progression and prognosis of COVID ‐19
inferredcites →https://doi.org/10.1002/dmrr.3321openalex-snapshot
Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics
inferredcites →https://doi.org/10.1002/hep.22429openalex-snapshot
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
inferredcites →https://doi.org/10.1002/hep.30506openalex-snapshot
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/oby.22831openalex-snapshot
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation
inferredcites →https://doi.org/10.1002/oby.22859openalex-snapshot
Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019
inferredcites →https://doi.org/10.1002/path.1570openalex-snapshot
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
inferredcites →https://doi.org/10.1007/s00109-019-01765-1openalex-snapshot
Innate immune regulatory networks in hepatic lipid metabolism
inferredcites →https://doi.org/10.1007/s00204-020-02734-1openalex-snapshot
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
inferredcites →https://doi.org/10.1007/s10620-011-1736-5openalex-snapshot
Fatty Liver Is Associated with Recurrent Bacterial Infections Independent of Metabolic Syndrome
inferredcites →https://doi.org/10.1007/s11684-020-0754-0openalex-snapshot
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
inferredcites →https://doi.org/10.1016/j.bbadis.2020.165753openalex-snapshot
Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles
inferredcites →https://doi.org/10.1016/j.bbrc.2020.03.044openalex-snapshot
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.cgh.2018.11.037openalex-snapshot
Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study
inferredcites →https://doi.org/10.1016/j.clinre.2019.04.005openalex-snapshot
Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment
inferredcites →https://doi.org/10.1016/j.diabet.2018.09.003openalex-snapshot
Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach
inferredcites →https://doi.org/10.1016/j.diabres.2014.04.006openalex-snapshot
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
inferredcites →https://doi.org/10.1016/j.ebiom.2020.102763openalex-snapshot
Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients
inferredcites →https://doi.org/10.1016/j.ejim.2017.10.020openalex-snapshot
Obesity phenotypes and their paradoxical association with cardiovascular diseases
inferredcites →https://doi.org/10.1016/j.ijcard.2018.01.046openalex-snapshot
Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis
inferredcites →https://doi.org/10.1016/j.jacc.2006.09.032openalex-snapshot
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
inferredcites →https://doi.org/10.1016/j.jacc.2010.05.034openalex-snapshot
The Metabolic Syndrome and Cardiovascular Risk
inferredcites →https://doi.org/10.1016/j.jaut.2020.102433openalex-snapshot
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
inferredcites →https://doi.org/10.1016/j.jhep.2015.11.004openalex-snapshot
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2016.09.022openalex-snapshot
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
inferredcites →https://doi.org/10.1016/j.jhep.2020.03.044openalex-snapshot
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
inferredcites →https://doi.org/10.1016/j.jhep.2020.04.035openalex-snapshot
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2020.04.039openalex-snapshot
Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
inferredcites →https://doi.org/10.1016/j.mce.2008.09.020openalex-snapshot
The sweeter side of ACE2: Physiological evidence for a role in diabetes
inferredcites →https://doi.org/10.1016/j.medin.2009.12.005openalex-snapshot
Gripe A pandémica en una unidad de cuidados intensivos: experiencia en España y Latinoamérica (Grupo Español de Trabajo de Gripe A Grave/Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias)
inferredcites →https://doi.org/10.1016/j.metabol.2009.09.012openalex-snapshot
The possible role of liver steatosis in defining metabolic syndrome in prepubertal children
inferredcites →https://doi.org/10.1016/j.metabol.2020.154244openalex-snapshot
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s0140-6736(20)30566-3openalex-snapshot
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
inferredcites →https://doi.org/10.1016/s0140-6736(20)30628-0openalex-snapshot
COVID-19: consider cytokine storm syndromes and immunosuppression
inferredcites →https://doi.org/10.1016/s0140-6736(20)31024-2openalex-snapshot
Obesity could shift severe COVID-19 disease to younger ages
inferredcites →https://doi.org/10.1016/s2213-2600(20)30076-xopenalex-snapshot
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
inferredcites →https://doi.org/10.1016/s2213-2600(20)30079-5openalex-snapshot
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
inferredcites →https://doi.org/10.1016/s2468-1253(20)30057-1openalex-snapshot
Liver injury in COVID-19: management and challenges
inferredcites →https://doi.org/10.1016/s2468-1253(20)30084-4openalex-snapshot
COVID-19 and the liver: little cause for concern
inferredcites →https://doi.org/10.1038/nature02145openalex-snapshot
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
inferredcites →https://doi.org/10.1038/nature05488openalex-snapshot
Abdominal obesity and metabolic syndrome
inferredcites →https://doi.org/10.1038/ni.2691openalex-snapshot
Immune surveillance by the liver
inferredcites →https://doi.org/10.1038/nm.2627openalex-snapshot
The cellular and signaling networks linking the immune system and metabolism in disease
inferredcites →https://doi.org/10.1038/oby.2010.291openalex-snapshot
Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik Study
inferredcites →https://doi.org/10.1038/oby.2010.86openalex-snapshot
Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic Syndrome
inferredcites →https://doi.org/10.1038/s41569-020-0360-5openalex-snapshot
COVID-19 and the cardiovascular system
inferredcites →https://doi.org/10.1038/s41574-018-0096-zopenalex-snapshot
The role of hypoxia-inducible factors in metabolic diseases
inferredcites →https://doi.org/10.1053/j.gastro.2016.01.025openalex-snapshot
Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
inferredcites →https://doi.org/10.1053/j.gastro.2019.11.312openalex-snapshot
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2020.02.054openalex-snapshot
COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission
inferredcites →https://doi.org/10.1053/j.gastro.2020.04.008openalex-snapshot
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California
inferredcites →https://doi.org/10.1053/j.gastro.2020.04.017openalex-snapshot
Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States
inferredcites →https://doi.org/10.1056/nejmoa2002032openalex-snapshot
Clinical Characteristics of Coronavirus Disease 2019 in China
inferredcites →https://doi.org/10.1056/nejmp2004361openalex-snapshot
History in a Crisis — Lessons for Covid-19
inferredcites →https://doi.org/10.1093/ajcn/34.8.1617openalex-snapshot
The “metabolically-obese,” normal-weight individual
inferredcites →https://doi.org/10.1093/ajcn/80.1.1openalex-snapshot
Cholesterol gallstones: a fellow traveler with metabolic syndrome
inferredcites →https://doi.org/10.1093/ije/dyx091openalex-snapshot
Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study
inferredcites →https://doi.org/10.1093/qjmed/hcy227openalex-snapshot
Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia
inferredcites →https://doi.org/10.1101/2020.01.30.927806openalex-snapshot
The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes
inferredcites →https://doi.org/10.1101/2020.02.03.931766openalex-snapshot
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
inferredcites →https://doi.org/10.1111/1751-2980.12851openalex-snapshot
2019 Novel coronavirus infection and gastrointestinal tract
inferredcites →https://doi.org/10.1111/dme.13565openalex-snapshot
European Association for the Study of the Liver ( EASL ), European Association for the Study of Diabetes ( EASD ) and European Association for the Study of Obesity ( EASO ) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in…
inferredcites →https://doi.org/10.1111/eci.12958openalex-snapshot
Exercising the hepatobiliary‐gut axis. The impact of physical activity performance
inferredcites →https://doi.org/10.1111/eci.13276openalex-snapshot
COVID‐19: Focus on the lungs but do not forget the gastrointestinal tract
inferredcites →https://doi.org/10.1111/eci.13338openalex-snapshot
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
inferredcites →https://doi.org/10.1111/irv.12618openalex-snapshot
Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses
inferredcites →https://doi.org/10.1111/j.1365-2036.2007.03586.xopenalex-snapshot
Adipokines and cytokines in non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1365-2265.2009.03742.xopenalex-snapshot
Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study
inferredcites →https://doi.org/10.1111/joim.12483openalex-snapshot
Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
inferredcites →https://doi.org/10.1111/liv.14091openalex-snapshot
Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms
inferredcites →https://doi.org/10.1111/liv.14484openalex-snapshot
Potential implications of COVID‐19 in non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1126/science.1260419openalex-snapshot
Tissue-based map of the human proteome
inferredcites →https://doi.org/10.1128/jvi.79.23.14614-14621.2005openalex-snapshot
ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia
inferredcites →https://doi.org/10.1136/bmj.m1091openalex-snapshot
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
inferredcites →https://doi.org/10.1136/bmj.m1966openalex-snapshot
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
inferredcites →https://doi.org/10.1136/gut.2004.062398openalex-snapshot
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
inferredcites →https://doi.org/10.1136/gutjnl-2020-320832openalex-snapshot
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus
inferredcites →https://doi.org/10.1136/gutjnl-2020-321013openalex-snapshot
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
inferredcites →https://doi.org/10.1136/gutjnl-2020-321611openalex-snapshot
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
inferredcites →https://doi.org/10.1136/jim-2016-000155openalex-snapshot
Overnutrition, Ectopic Lipid and the Metabolic Syndrome
inferredcites →https://doi.org/10.1146/annurev-pathmechdis-012418-013003openalex-snapshot
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
inferredcites →https://doi.org/10.1152/ajpendo.00052.2019openalex-snapshot
Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway
inferredcites →https://doi.org/10.1159/000282080openalex-snapshot
Epidemiology of Non-Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1159/000357718openalex-snapshot
Anthropometric, Hemodynamic, Metabolic, and Renal Responses during 5 Days of Food and Water Deprivation
inferredcites →https://doi.org/10.1161/atvbaha.107.151092openalex-snapshot
Metabolic Syndrome Pandemic
inferredcites →https://doi.org/10.1161/circulationaha.107.739920openalex-snapshot
Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1161/circulationaha.109.192644openalex-snapshot
Harmonizing the Metabolic Syndrome
inferredcites →https://doi.org/10.1164/rccm.202001-0179leopenalex-snapshot
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2
inferredcites →https://doi.org/10.1172/jci137647openalex-snapshot
SARS-CoV-2: a storm is raging
inferredcites →https://doi.org/10.1371/journal.pmed.1001053openalex-snapshot
Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis
inferredcites →https://doi.org/10.14218/jcth.2020.00018openalex-snapshot
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
inferredcites →https://doi.org/10.14218/jcth.2020.00019openalex-snapshot
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease
inferredcites →https://doi.org/10.14218/jcth.2020.00024openalex-snapshot
What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
inferredcites →https://doi.org/10.1503/cmaj.051299openalex-snapshot
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies
inferredcites →https://doi.org/10.1515/cclm-2020-0369openalex-snapshot
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
inferredcites →https://doi.org/10.1517/13543784.2015.974804openalex-snapshot
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
inferredcites →https://doi.org/10.18632/aging.102488openalex-snapshot
HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway
inferredcites →https://doi.org/10.18632/aging.103000openalex-snapshot
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
inferredcites →https://doi.org/10.22037/aaem.v8i1.590openalex-snapshot
Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor.
inferredcites →https://doi.org/10.2337/diabetes.47.5.699openalex-snapshot
The metabolically obese, normal-weight individual revisited.
inferredcites →https://doi.org/10.2807/1560-7917.es.2020.25.13.2000323openalex-snapshot
Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020
inferredcites →https://doi.org/10.2967/jnumed.120.246256openalex-snapshot
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
inferredcites →https://doi.org/10.3389/fendo.2019.00071openalex-snapshot
Influence of Obesity on Pneumococcus Infection Risk in the Elderly
inferredcites →https://doi.org/10.3389/fpubh.2016.00279openalex-snapshot
Overfat and Underfat: New Terms and Definitions Long Overdue
inferredcites →https://doi.org/10.3389/fpubh.2017.00190openalex-snapshot
Overfat Adults and Children in Developed Countries: The Public Health Importance of Identifying Excess Body Fat
inferredcites →https://doi.org/10.3389/fpubh.2017.00290openalex-snapshot
The Prevalence of Overfat Adults and Children in the US
inferredcites →https://doi.org/10.3390/nu12020564openalex-snapshot
Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
inferredcites →https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003openalex-snapshot
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].
inferredcites →https://doi.org/10.46234/ccdcw2020.032openalex-snapshot
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4797163openalex-extracted
Mesenchymal Stromal Cell Secretome Restores Immune Profile Towards Tissue Regeneration in a Model of Liver Fibrosis with Acute Lung Injury
inferred← citeshttps://doi.org/10.1002/cld.1169openalex-snapshot
The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection
inferred← citeshttps://doi.org/10.1002/ctm2.1801openalex-snapshot
A novel peptide encoded by circ‐SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac‐mediated CD36 transcription in NAFLD
inferred← citeshttps://doi.org/10.1002/hep4.1957openalex-snapshot
Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019
inferred← citeshttps://doi.org/10.1002/jmv.70964openalex-snapshot
FIB‐4 Index and APRI Score Predict Short‐ and Long‐Term Mortality in Hospitalized COVID‐19 Patients: A 4‐Year Follow‐Up Study
inferred← citeshttps://doi.org/10.1007/s00330-025-11851-3openalex-snapshot
Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients
inferred← citeshttps://doi.org/10.1007/s00535-021-01778-zopenalex-snapshot
The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10528-021-10144-wopenalex-snapshot
Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis
inferred← citeshttps://doi.org/10.1007/s10620-021-07120-0openalex-snapshot
Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10787-024-01535-7openalex-snapshot
Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management
inferred← citeshttps://doi.org/10.1007/s11517-022-02505-3openalex-snapshot
Exploring diet associations with Covid-19 and other diseases: a Network Analysis–based approach
inferred← citeshttps://doi.org/10.1007/s11739-023-03203-0openalex-snapshot
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
inferred← citeshttps://doi.org/10.1007/s13300-022-01318-9openalex-snapshot
Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study
inferred← citeshttps://doi.org/10.1007/s13337-022-00793-9openalex-snapshot
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview
inferred← citeshttps://doi.org/10.1016/b978-0-323-90144-4.00008-2openalex-snapshot
Microbiome and the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/b978-0-443-26711-6.00046-9openalex-snapshot
COVID-19 and the liver
inferred← citeshttps://doi.org/10.1016/j.aohep.2020.09.015openalex-snapshot
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
inferred← citeshttps://doi.org/10.1016/j.aohep.2021.100653openalex-snapshot
Management of COVID-19 patients with chronic liver diseases and liver transplants
inferred← citeshttps://doi.org/10.1016/j.aohep.2026.102224openalex-snapshot
Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112221openalex-snapshot
Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.10.009openalex-snapshot
Reply
inferred← citeshttps://doi.org/10.1016/j.clinre.2021.101807openalex-snapshot
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105549openalex-snapshot
Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology
inferred← citeshttps://doi.org/10.1016/j.dsx.2021.03.019openalex-snapshot
Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104912openalex-snapshot
Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study
inferred← citeshttps://doi.org/10.1016/j.jceh.2022.11.010openalex-snapshot
Clinical Trajectory and Predictors of Intensive Care Unit Mortality Among Nonalcoholic Fatty Liver Disease Patients: A Retrospective Case–Control Study
inferred← citeshttps://doi.org/10.1016/j.lfs.2024.123022openalex-snapshot
COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.livres.2023.07.001openalex-snapshot
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups
inferred← citeshttps://doi.org/10.1021/acsnano.0c08494openalex-snapshot
Emerging Telemedicine Tools for Remote COVID-19 Diagnosis, Monitoring, and Management
inferred← citeshttps://doi.org/10.1037/neu0000731openalex-snapshot
Neuropsychology of COVID-19: Anticipated cognitive and mental health outcomes.
inferred← citeshttps://doi.org/10.1038/s41385-021-00404-8openalex-snapshot
Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution
inferred← citeshttps://doi.org/10.1038/s41387-024-00294-2openalex-snapshot
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition
inferred← citeshttps://doi.org/10.1080/00365521.2020.1842489openalex-snapshot
No association between COVID-19 related liver injury and the course of disease: a retrospective study
inferred← citeshttps://doi.org/10.1080/14787210.2021.1964955openalex-snapshot
Anti-inflammatory effects of GLP-1 in patients with COVID-19
inferred← citeshttps://doi.org/10.1080/15321819.2024.2429538openalex-snapshot
Impacts of host factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression
inferred← citeshttps://doi.org/10.1080/17474124.2020.1801417openalex-snapshot
MAFLD in COVID-19 patients: an insidious enemy
inferred← citeshttps://doi.org/10.1080/19490976.2022.2100200openalex-snapshot
Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters
inferred← citeshttps://doi.org/10.1089/vim.2020.0330openalex-snapshot
Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis
inferred← citeshttps://doi.org/10.1093/jleuko/qiaf094openalex-snapshot
Metainflammation alters neutrophil function and migration in vivo in response to tissue injury
inferred← citeshttps://doi.org/10.1093/med/9780198816805.003.0074openalex-snapshot
Viral alcoholic and fatty liver diseases
inferred← citeshttps://doi.org/10.1097/mcg.0000000000001481openalex-snapshot
COVID-19 in Chronic Liver Disease and Liver Transplantation
inferred← citeshttps://doi.org/10.1097/md.0000000000033912openalex-snapshot
Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/meg.0000000000002091openalex-snapshot
Fibrosis-4 index and mortality in coronavirus disease 2019: a meta-analysis
inferred← citeshttps://doi.org/10.1101/2021.06.17.448814openalex-snapshot
Western diet increases COVID-19 disease severity in the Syrian hamster
inferred← citeshttps://doi.org/10.1101/2021.10.03.462893openalex-snapshot
Neutrophil reverse migration from liver fuels neutrophilic inflammation to tissue injury in Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1111/eci.13597openalex-snapshot
Multiplying effects of COVID‐19 lockdown on metabolic risk and fatty liver
inferred← citeshttps://doi.org/10.1111/eci.13682openalex-snapshot
Noncommunicable diseases, climate change and iniquities: What COVID‐19 has taught us about syndemic
inferred← citeshttps://doi.org/10.1111/liv.15061openalex-snapshot
COVID‐19, adaptative immune response and metabolic‐associated liver disease
inferred← citeshttps://doi.org/10.1177/22799036221115779openalex-snapshot
May an incidental finding on chest CT be a predictor of access in intensive care unit? Role of hepatic steatosis in patients affected by SARS-CoV-2
inferred← citeshttps://doi.org/10.1177/26339447251338134openalex-snapshot
Investigating the Association Between Gynecomastia and Fatty Liver and Epicardial Fat in Patients with COVID-19 *
inferred← citeshttps://doi.org/10.1186/s12944-021-01564-zopenalex-snapshot
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
inferred← citeshttps://doi.org/10.1186/s12979-020-00212-xopenalex-snapshot
Obesity and COVID-19: what makes obese host so vulnerable?
inferred← citeshttps://doi.org/10.1186/s40001-021-00590-yopenalex-snapshot
Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study
inferred← citeshttps://doi.org/10.1186/s43066-021-00131-6openalex-snapshot
Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity—a computed tomography study
inferred← citeshttps://doi.org/10.12998/wjcc.v10.i7.2063openalex-snapshot
Patterns of liver profile disturbance in patients with COVID-19
inferred← citeshttps://doi.org/10.12998/wjcc.v11.i6.1275openalex-snapshot
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
inferred← citeshttps://doi.org/10.12998/wjcc.v9.i12.2711openalex-snapshot
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
inferred← citeshttps://doi.org/10.12998/wjcc.v9.i31.9333openalex-snapshot
Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids
inferred← citeshttps://doi.org/10.1371/journal.pone.0243700openalex-snapshot
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
inferred← citeshttps://doi.org/10.1371/journal.pone.0289202openalex-snapshot
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System
inferred← citeshttps://doi.org/10.1371/journal.pone.0323708openalex-snapshot
Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B
inferred← citeshttps://doi.org/10.14744/lhhs.2023.40001openalex-snapshot
Hepatosteatosis Patients with Pseudocontrast Sign in COVID-19: Relationships with Disease Severity and Survival Times
inferred← citeshttps://doi.org/10.15829/1560-4071-2022-4979openalex-snapshot
Associations of changes in lipid metabolism parameters and the severity of COVID-19 infection in Novosibirsk residents
inferred← citeshttps://doi.org/10.17179/excli2021-3417openalex-snapshot
Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021
inferred← citeshttps://doi.org/10.18699/ssmj20210608openalex-snapshot
Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19
inferred← citeshttps://doi.org/10.18699/ssmj20220101openalex-snapshot
Metabolic disorders and the risk of COVID-19
inferred← citeshttps://doi.org/10.20517/mtod.2022.14openalex-snapshot
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
inferred← citeshttps://doi.org/10.20517/mtod.2022.36openalex-snapshot
The bidirectional relationship between fatty liver disease and COVID-19
inferred← citeshttps://doi.org/10.21037/apm-21-1398openalex-snapshot
Liver injury in COVID-19 patients with metabolic syndrome—a narrative review
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2781976/v1openalex-snapshot
Association of gynecomastia and fatty liver and epicardial fat in COVID-19 patients
inferred← citeshttps://doi.org/10.21203/rs.3.rs-69885/v1openalex-snapshot
Chronic Liver Disease and COVID-19: A Perspective From Singapore
inferred← citeshttps://doi.org/10.21203/rs.3.rs-77057/v1openalex-snapshot
Correlation Between COVID-19 Severity, Body Mass Index and Hepatic Steatosis: A Retrograde Cohort Study
inferred← citeshttps://doi.org/10.2174/1871526522666220407001744openalex-snapshot
COVID-19 and Coinfections: A Serious Health Threat Requires Combination of Diagnosis and Therapy
inferred← citeshttps://doi.org/10.21873/anticanres.14999openalex-snapshot
Obesity and Liver Cancer in Japan: A Comprehensive Review
inferred← citeshttps://doi.org/10.22141/2308-2097.59.1.2025.659openalex-snapshot
The impact of liver steatosis on the severity of COVID-19 in patients with chronic coronary syndrome
inferred← citeshttps://doi.org/10.22141/2308-2097.59.1.2025.661openalex-snapshot
Evaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2
inferred← citeshttps://doi.org/10.22141/2308-2097.59.4.2025.703openalex-snapshot
Correlations of clinical and diagnostic indicators in patients with metabolic-associated steatotic liver disease with the immune response to SARS-CoV-2
inferred← citeshttps://doi.org/10.22541/au.160396940.06060173/v1openalex-snapshot
Abnormal Baseline liver function tests are associated with death or mechanical ventilation in COVID-19
inferred← citeshttps://doi.org/10.23880/jqhe-16000225openalex-snapshot
Diabetes, Heart Disease, Fatty Liver, Blood Groups and COVID-19 Disease: A Brief Review of Evidences
inferred← citeshttps://doi.org/10.24875/arm.22000014openalex-snapshot
Esteatosis hepática asociada a la severidad de la neumonía por COVID-19 por tomografía
inferred← citeshttps://doi.org/10.24911/sjp.106-1636877693openalex-snapshot
Acute hepatitis with non-alcoholic fatty liver disease-expanding clinical spectrum in COVID-19 exposed children: case report and review of literature
inferred← citeshttps://doi.org/10.26820/reciamuc/5.(1).ene.2021.392-400openalex-snapshot
Esteatosis hepática y COVID tratamiento y pronóstico
inferred← citeshttps://doi.org/10.29254/2077-4214-2024-2-173-45-51openalex-snapshot
COVID-19 AND ASSOCIATED WITH METABOLIC DYSFUNCTION HEPATOSTEATOSIS: LITERATURE REVIEW
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-187-3-178-185openalex-snapshot
Liver damage while Covid-19: problems of pathogenesis and treatment
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-203-7-131-144openalex-snapshot
Features of respiratory tests (hydrogen + methane), indirect liver elastometry data in COVID-19 convalescents (pilot study)
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-206-10-163-168openalex-snapshot
A new challenge for the liver in the 21st century
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-220-12-140-147openalex-snapshot
Hyperammonemia as a manifestation of post-covid syndrome in patients with nonalcoholic fatty liver disease: post-hoc analysis of the LIRA - COVID observational clinical program
inferred← citeshttps://doi.org/10.31549/2542-1174-2023-7-1-132-148openalex-snapshot
Comparative analysis of the dynamics of clinical and functional features of the metabolic syndrome in COPD patients who had a novel coronavirus infection
inferred← citeshttps://doi.org/10.33448/rsd-v10i16.24261openalex-snapshot
Food consumption and factors related to weight variation in patients with Non-Alcoholic Fatty Liver Disease during the COVID-19 pandemic
inferred← citeshttps://doi.org/10.3389/ebm.2025.10782openalex-snapshot
Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury
inferred← citeshttps://doi.org/10.3389/fgene.2024.1421824openalex-snapshot
Causal associations between severe COVID-19 and diseases of seven organs: a proteome-wide mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fimmu.2022.890517openalex-snapshot
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
inferred← citeshttps://doi.org/10.3389/fmed.2021.626425openalex-snapshot
Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis
inferred← citeshttps://doi.org/10.3389/fmicb.2022.1037467openalex-snapshot
Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
inferred← citeshttps://doi.org/10.3389/fmolb.2022.803314openalex-snapshot
Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue
inferred← citeshttps://doi.org/10.3389/fmolb.2023.1164220openalex-snapshot
Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis
inferred← citeshttps://doi.org/10.3389/fphys.2022.894044openalex-snapshot
Effect of Exercise Training on Serum Transaminases in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/biomedicines12020283openalex-snapshot
Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?
inferred← citeshttps://doi.org/10.3390/jcm9082648openalex-snapshot
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
inferred← citeshttps://doi.org/10.3390/life14010093openalex-snapshot
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
inferred← citeshttps://doi.org/10.3390/medicina57050434openalex-snapshot
The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis
inferred← citeshttps://doi.org/10.3390/medicina57101057openalex-snapshot
Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
inferred← citeshttps://doi.org/10.3390/nu14142795openalex-snapshot
Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
inferred← citeshttps://doi.org/10.3390/pathogens11070816openalex-snapshot
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
inferred← citeshttps://doi.org/10.3390/v13122506openalex-snapshot
High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster
inferred← citeshttps://doi.org/10.3390/v14092067openalex-snapshot
Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters
inferred← citeshttps://doi.org/10.34297/ajbsr.2021.13.001854openalex-snapshot
Diabetes, Heart Disease, Fatty Liver, Blood Groups And COVID-19 Disease: A Brief Review of Evidence
inferred← citeshttps://doi.org/10.35366/107628openalex-snapshot
Dislipidemias, hígado graso y enfermedad cardiovascular
inferred← citeshttps://doi.org/10.37345/23045329.v1i33.86openalex-snapshot
Relación entre esteatosis hepática y enfermedad pulmonar severa por SARS Cov-2 según criterios radiológicos
inferred← citeshttps://doi.org/10.3748/wjg.v27.i13.1296openalex-snapshot
COVID-19 and comorbidities of hepatic diseases in a global perspective
inferred← citeshttps://doi.org/10.3748/wjg.v27.i16.1738openalex-snapshot
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
inferred← citeshttps://doi.org/10.3748/wjg.v27.i22.3064openalex-snapshot
COVID-19 and pediatric fatty liver disease: Is there interplay?
inferred← citeshttps://doi.org/10.3748/wjg.v27.i26.3951openalex-snapshot
Liver dysfunction and SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.3748/wjg.v27.i33.5502openalex-snapshot
Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19
inferred← citeshttps://doi.org/10.3748/wjg.v27.i36.6039openalex-snapshot
Liver disease in the era of COVID-19: Is the worst yet to come?
inferred← citeshttps://doi.org/10.3748/wjg.v27.i9.782openalex-snapshot
Interaction between hepatitis B virus and SARS-CoV-2 infections
inferred← citeshttps://doi.org/10.3748/wjg.v28.i41.5910openalex-snapshot
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
inferred← citeshttps://doi.org/10.3748/wjg.v29.i14.2064openalex-snapshot
Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies
inferred← citeshttps://doi.org/10.3748/wjg.v29.i3.487openalex-snapshot
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
inferred← citeshttps://doi.org/10.3748/wjg.v29.i6.908openalex-snapshot
COVID-19 and liver injury in individuals with obesity
inferred← citeshttps://doi.org/10.3748/wjg.v30.i11.1480openalex-snapshot
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
inferred← citeshttps://doi.org/10.4067/s0717-95022021000401096openalex-snapshot
Correlation Between COVID-19 Severity, Body Mass Index and Radiological Hepatic Morphology
inferred← citeshttps://doi.org/10.4103/jpdtsm.jpdtsm_50_25openalex-snapshot
Long-term Hepatic Sequelae of Mild Coronavirus Disease 2019: Elevated Liver Enzymes at 10-month Follow-up
inferred← citeshttps://doi.org/10.4103/sjg.sjg_540_20openalex-snapshot
The effect of hepatic steatosis on COVID-19 severity
inferred← citeshttps://doi.org/10.4254/wjh.v13.i10.1367openalex-snapshot
Liver and COVID-19: From care of patients with liver diseases to liver injury
inferred← citeshttps://doi.org/10.4254/wjh.v13.i5.522openalex-snapshot
COVID-19 and the liver: What do we know so far?
inferred← citeshttps://doi.org/10.4254/wjh.v13.i8.916openalex-snapshot
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
inferred← citeshttps://doi.org/10.4254/wjh.v16.i8.1185openalex-snapshot
Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review
inferred← citeshttps://doi.org/10.4254/wjh.v18.i2.113004openalex-snapshot
Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study
inferred← citeshttps://doi.org/10.52403/ijrr.20221224openalex-snapshot
Telemedicine and Biosensors, A Boon in COVID Era: An Update
inferred← citeshttps://doi.org/10.54005/geneltip.1274160openalex-snapshot
The Effect of Hepatosteatosis on the Course of Chest CT Severity Scores in COVID-19 Patients
inferred← citeshttps://doi.org/10.54718/ryte6013openalex-snapshot
Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All
inferred← citeshttps://doi.org/10.5501/wjv.v12.i1.22openalex-snapshot
Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment
inferred← citeshttps://doi.org/10.5772/intechopen.103785openalex-snapshot
COVID-19 Outcomes and Liver Disease
inferred← citeshttps://doi.org/10.7150/ijbs.72461openalex-snapshot
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD
inferred← citeshttps://doi.org/10.7150/ijbs.76035openalex-snapshot
The global battle against SARS-CoV-2 and COVID-19 at the third year
inferred← citeshttps://doi.org/10.7150/thno.59293openalex-snapshot
Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities
inferred← citeshttps://doi.org/10.7573/dic.2021-9-4openalex-snapshot
Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL* protocol
inferred← citeshttps://doi.org/10.7759/cureus.20776openalex-snapshot
Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
inferred← citeshttps://doi.org/10.7759/cureus.29657openalex-snapshot
A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review
inferred← citeshttps://doi.org/10.7759/cureus.45231openalex-snapshot
The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
showing the first 141 of 142 · page through all 142
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.